Masayori Moriyama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Masayori Moriyama has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Kentaro Noda
Division of Rheumatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
3 shared publications Daitaro Kurosaka
Division of Rheumatology, Department of Internal Medicine The Jikei University School of Medicine Tokyo Japan
2 shared publications- Anna Hasegawa
Department of Rheumatology, Dokkyo Medical University , Mibu
1 shared publication Arisa Hirayama
Department of Dermatology, The Jikei University Kashiwa Hospital
1 shared publication- Atsuki Furube
Department of Respiratory Medicine, The Jikei University Kashiwa Hospital
1 shared publication - Ayaka Maeda
Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine , Yokohama
1 shared publication
Latest Publications
- 1 April 2026
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 85 (10) , 2033-2043
Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study
- 1 April 2026
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 85 (10) , 2033-2043
Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study
- Open Access
- 22 June 2023
- Published by Oxford University Press (OUP) in Modern Rheumatology Case Reports
- Vol. 8 (1) , 63-68
Clinical features of newly diagnosed systemic lupus erythematosus after SARS-CoV-2 vaccination
Systemic lupus erythematosus (SLE) is an autoimmune disease that causes damage to multiple organs. Various factors, including vaccination, have been associated with SLE development. Vaccination for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in 2020, and there are a few reports on the exacerbation of SLE after SARS-CoV-2 vaccination. The influence of SARS-CoV-2 vaccination on SLE development remains unclear. We present the case of a 53-year-old man who developed peritonitis and was subsequently diagnosed with SLE on Day 9 after receiving a third dose of the messenger ribonucleic acid-1273 SARS-CoV-2 vaccine. This case and previous reports have shown that patients who developed SLE after SARS-CoV-2 vaccination are more likely to develop it within 2 weeks of vaccination, especially when they have a higher rate of immunological abnormalities or a family history of autoimmune diseases. Furthermore, these features suggest that type I interferon is involved in the pathogenesis of SLE after SARS-CoV-2 vaccination.
- 22 June 2023
- Published by Oxford University Press (OUP) in Modern Rheumatology Case Reports
- Vol. 8 (1) , 63-68
Open AccessClinical features of newly diagnosed systemic lupus erythematosus after SARS-CoV-2 vaccination
Systemic lupus erythematosus (SLE) is an autoimmune disease that causes damage to multiple organs. Various factors, including vaccination, have been associated with SLE development. Vaccination for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in 2020, and there are a few reports on the exacerbation of SLE after SARS-CoV-2 vaccination. The influence of SARS-CoV-2 vaccination on SLE development remains unclear. We present the case of a 53-year-old man who developed peritonitis and was subsequently diagnosed with SLE on Day 9 after receiving a third dose of the messenger ribonucleic acid-1273 SARS-CoV-2 vaccine. This case and previous reports have shown that patients who developed SLE after SARS-CoV-2 vaccination are more likely to develop it within 2 weeks of vaccination, especially when they have a higher rate of immunological abnormalities or a family history of autoimmune diseases. Furthermore, these features suggest that type I interferon is involved in the pathogenesis of SLE after SARS-CoV-2 vaccination.
- Open Access
- 20 May 2023
- Published by The Japanese Association for Infectious Diseases in Kansenshogaku Zasshi
- Vol. 97 (3) , 104-110
全身性エリテマトーデス治療中に致死的経過を辿った播種性クリプトコックス症の1例
A 62-year-old female patient under long-term corticosteroid therapy for systemic lupus erythematosus consulted our hospital for generalized malaise and was subsequently admitted to the hospital with the diagnosis of prerenal renal failure. During hospitalization, right lateral abdominal erythema and an elevated serum C-reactive protein level were observed. Chest computed tomography showed multiple nodular shadows in the right upper lung lobe. Thereafter, Cryptococcus neoformans was isolated from the blood and skin biopsy samples obtained from the erythematous region in the right lateral abdomen. Based on the findings, we established the diagnosis of disseminated cryptococcosis. Although the patient was immediately initiated on antifungal treatments, she developed cerebral infarction and pancreatitis, which were possibly attributed to the disseminated cryptococcosis. Subsequently, she rapidly developed evidence of disseminated intravascular coagulation syndrome and multiple organ failure, resulting in death. Herein, we report a case of disseminated cryptococcosis, in which detailed microbiological and pathological analysis was conducted.
- 20 May 2023
- Published by The Japanese Association for Infectious Diseases in Kansenshogaku Zasshi
- Vol. 97 (3) , 104-110
Open Access全身性エリテマトーデス治療中に致死的経過を辿った播種性クリプトコックス症の1例
A 62-year-old female patient under long-term corticosteroid therapy for systemic lupus erythematosus consulted our hospital for generalized malaise and was subsequently admitted to the hospital with the diagnosis of prerenal renal failure. During hospitalization, right lateral abdominal erythema and an elevated serum C-reactive protein level were observed. Chest computed tomography showed multiple nodular shadows in the right upper lung lobe. Thereafter, Cryptococcus neoformans was isolated from the blood and skin biopsy samples obtained from the erythematous region in the right lateral abdomen. Based on the findings, we established the diagnosis of disseminated cryptococcosis. Although the patient was immediately initiated on antifungal treatments, she developed cerebral infarction and pancreatitis, which were possibly attributed to the disseminated cryptococcosis. Subsequently, she rapidly developed evidence of disseminated intravascular coagulation syndrome and multiple organ failure, resulting in death. Herein, we report a case of disseminated cryptococcosis, in which detailed microbiological and pathological analysis was conducted.